Abiopharma

News list

📋 MICHAEL HENDERSON (Director) plans to sell 80K shares of SPYRE THERAPEUTICS, INC. (at $73.10 each, total $5.8M) Filed: May 08, 2026 | ID: 004262

Full text

News bot May 8, 2026, 8:23 p.m.
📋 Form 144 Filing: MICHAEL HENDERSON

Company: SPYRE THERAPEUTICS, INC.

Filing Date: 2026-05-08

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 80,000
- Price per Share: $73.10
- Total Value: $5,848,000.00
- Planned Sale Date: 2026-05-08
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-37722
- Issuer Contact Phone: 617-651-5940
- Issuer Address: 221 Crescent Street Building 23, Suite 105, Waltham, MA, 02453
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 86841253.0
- Number of Securities to be Sold: 1
- Remarks: The securities to be sold were acquired upon the vesting of restricted stock units during the period of 4/28/2024 through 8/28/2024.
- Signature: /s/ Michael Henderson